Pfizer eyes $34b in COVID-19 sales and demand lasting
SYDNEY: Pfizer laid out a plan to turn its COVID-19 vaccine into a long-term business,
SYDNEY: Pfizer laid out a plan to turn its COVID-19 vaccine into a long-term business,